Here's what typical patients experience: Week 1-2: Minimal Scale Changes, Major Benefits Expected Fat Loss: 1-2 lbs Muscle Gain: 0-0.5 lbs What's Happening: Sleep quality dramatically improves Energy levels increase Recovery from workouts noticeably better Some initial water weight loss GH levels elevating and fat mobilization beginning Week 3-4: Scale Starts Moving Expected Total Fat Loss: 3-5 lbs Muscle Gain: 0.5-1 lb What's Happening: Consistent fat loss becoming evident Face appears less puffy Slight improvements in how clothes fit Strength increasing in gym Mental clarity and mood improving Week 5-8: Visible Body Composition Changes Expected Total Fat Loss: 8-12 lbs Muscle Gain: 1-2 lbs What's Happening: Clothes fitting noticeably looser Waistline reducing by 1-2 inches Muscle definition starting to show Others commenting on changes Photos show clear difference from start Week 9-16: Major Transformation Expected Total Fat Loss: 15-25 lbs Muscle Gain: 3-5 lbs What's Happening: Dramatic reduction in waist/hip measurements (3-4 inches) Stubborn fat areas finally shrinking Significant muscle definition visible Friends/family amazed by transformation May need new wardrobe Week 17-24: Peak Transformation Expected Total Fat Loss: 25-40+ lbs Muscle Gain: 5-8 lbs What's Happening: Total body transformation complete Visible abs/muscle separation 4-6+ inch waist reduction Before/after photos look like different people Optimal body composition achieved "More energy throughout the day and improved life in other ways
Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments
Endothelial cell senescence in aging-related vascular dysfunction
I haven't changed anything." These are not women who are not accustomed to tracking things and keeping really tight reins on their health, on their diet, on their stress, on their alcohol
Ultimately, the future of health research depends on these informed, meticulous decisions
Such proteolytic cleavage in the peptide would lead to the accumulation of long half-life metabolites able to suppress PCSK9 but inactive against GLP-1R
